- Home
- TGB vs LENZ Comparison
TGB vs LENZ Comparison
Compare TGB & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TGB | LENZ |
|---|---|---|
| Founded | 1966 | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 609.5M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TGB | LENZ |
|---|---|---|
| Price | $6.69 | $9.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $5.00 | ★ $45.60 |
| AVG Volume (30 Days) | ★ 5.0M | 1.1M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | $67.93 | $162.79 |
| Revenue Next Year | $24.16 | $170.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.67 | $8.25 |
| 52 Week High | $9.25 | $50.19 |
Technical Indicators
Market Signals| Indicator | TGB | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 39.79 |
| Support Level | $5.36 | N/A |
| Resistance Level | $9.08 | $12.70 |
| Average True Range (ATR) | 0.36 | 0.90 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 81.82 | 31.91 |
Price Performance
Historical ComparisonAbout TGB Taseko Mines Ltd.
Taseko Mines Ltd is a copper-focused mining company engaged in acquiring, developing, and operating large tonnage mineral deposits in stable jurisdictions that are capable of supporting a mine. Its principal assets are the wholly-owned Gibraltar mine (Gibraltar), which is located in central British Columbia (BC), and the Florence Copper mine, located in Arizona. Taseko also owns the Yellowhead copper, New Prosperity copper-gold, and Aley niobium projects in British Columbia, Canada.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.